hero-654791312-sized

Ensights

Science that is transforming lives and enabling the future

How Does Quality by Design Affect Bulk Drug Cold Chain Manufacturing?

All Posts

How Does Quality by Design Affect Bulk Drug Cold Chain Manufacturing?

As a world-class supplier of advanced materials and process solutions for the semiconductor space, we understand the complexity and challenges of quality by design with respect to bulk drug cold chain manufacturing. Costly failures can be devastating and, in many cases, can be avoided by partnering with the correct single-use solutions provider to help optimize critical processes. When looking for solutions to protect your therapeutics during bulk drug cold chain, keep the following in mind:


Protection

Is your current single-use solution performing up to regulatory standards? Safeguard your high value therapeutics from reactive, absorptive, additive single-use solutions that can compromise drug effectiveness by choosing a robust, inert material that can handle temperatures of -196°C (-320°F) while maintaining its physical properties. The right material will protect the integrity, efficacy, and purity of your product, which in many cases can be as important as the product itself.

life-sciences-tech-ctr-inline-image-1-12228-900x450Secondary Containment

Can your secondary containment withstand transport and storage challenges? Optimizing for controlled freeze/thaw and transport can help you get the most out of your process, saving time, money, and resources. Shells offering low storage density, freezer compatibility, intra-facility transfer, and frozen distribution enable maximum protection. These containment shells can be customized per application, offering high-quality throughput in an economical package. From lower cost intermediaries to high end therapeutics, Entegris shells offer maximum protection throughout the cold chain process.


Technology

Proper design and process capabilities are vital requirements when developing solutions to protect high value product, which ultimately creates opportunities to develop solutions in the protection of high value therapeutics. With the single-use market for bioprocess at $8B and growing, there is a tremendous need to move from traditional stainless steel to single-use technologies. We are a trusted partner that provides robust and reliable single-use solutions for bulk drug freeze, thaw, and transport. This is evident in the launch of our Life Sciences Technology Center. The Technology Center is open to partners looking to create high purity, robust solutions designed specifically for their process. Designed around our primary consumable, Aramus™ single-use bag assemblies, we combine world-class hardware with a complete plate freezing solution delivering quality by design systems.

quality-by-design-inline-10612-675x253By partnering with Entegris, you will reap the benefits of our expertise in cold-chain process and operations, bespoke solutions tailored to your process, and a working partnership with a well-resourced freeze/thaw ecosystem center. We back this with our robust global supply chain, operational excellence, and technology investments.

Let us help optimize your process.

Related Posts

Designing for Extended Performance in Life Science Contaminant Removal

Designing for Extended Performance in Life Science Contaminant Removal Filters have a finite lifetime, and their performance also changes over time. How do you get the most performance over the longest lifespan?

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers

Entegris Offers New FOUP Form-Factors for Non-Standard Wafers Over the last few years, 3D stacking has gone from a relatively niche fabrication method to an absolute necessity for cutting-edge applications. As chipmakers delve into smaller and smaller nodes, stacking and die-bonding wafers has become a preferred way of creating more processing power in a smaller space. Stacked and bonded wafers don’t behave the same way as 2D wafers: Wafers are thinned prior to bonding, which results in wafers that can sag when handled Bonded wafers are thicker and heavier than 2D wafers when assembled Bonded wafers can also warp following assembly Many automation tools rely on the predictable geometry and characteristics of 2D silicon wafers for safe handling and transport. While stacked and bonded wafers are a game-changer for miniaturization, they can also force manufacturing compromises unless chipmakers adopt specialized tools for the back end of the line (BEOL).

A Thermal Stability Study of Phosphoramidites Employed in Oligonucleotide Synthesis

A Thermal Stability Study of Phosphoramidites Employed in Oligonucleotide Synthesis In the dynamic world of drug design, thermal stability plays a crucial role, often determining the success of innovative treatments. As researchers push the boundaries of medicine, the need for robust and effective RNA- and DNA-based drugs has never been greater. This is where the phosphoramidite method of DNA synthesis shines, but understanding the thermal stability of its components, especially phosphoramidites, is essential. In this blog, we will explore why thermal stability is vital in drug development, delve into a study focused on phosphoramidites, and discuss its implications for the field.